CompaniesEchosens

Echosens

active

Paris, France

Founded 2001

Website

About

Live Diagnostic Technologies, Data Management Software

Areas of Focus

Categories

DiagnosticsMedical Measurement

Clinical Trials (43)

View all

Total Trials

As Lead Sponsor

As Collaborator

Total Enrollment

18,074

By Phase

NA: 26PHASE1: 1

By Status

COMPLETED: 19TERMINATED: 11UNKNOWN: 6WITHDRAWN: 4RECRUITING: 2ENROLLING_BY_INVITATION: 1

Clinical Trials Pipeline43 trials

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Phase 1/2

Phase 2/3

N/A

Phase

Status

Role

Condition

2004

2005

2006

2007

2008

2009

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

2020

2021

2022

2023

2024

2025

2026

2027

2028

2029

2030

2031

2032

Today

NCT00125762

FibroScan in Patients With Hepatitis B and C Presenting for Liver Biopsy

Phase: N/A

Role: Collaborator

Start: Mar 31, 2005

Completion: Oct 1, 2008

NCT00708617

FIBROSCAN Validation and Interest of Fibrotest - FIBROSCAN Association for Fibrosis Diagnosis in Alcoholic Liver Disease

Phase: N/A

Role: Collaborator

Start: Sep 30, 2008

Completion: Jul 31, 2013

NCT00708617

NCT00926224

Fibroscan® and Its Dedicated Probes Efficiency in Obese Patients

Phase: N/A

Role: Lead Sponsor

Start: Jul 31, 2009

Completion: Sep 30, 2010

NCT01089777

Monitoring and Characterization of Coronary Flow By Transthoracic Parametric Doppler (TPD) During Exercise Stress Test

Phase: N/A

Role: Lead Sponsor

Start: Apr 30, 2010

Completion: Feb 28, 2014

NCT01225367

The Use of a Ultra-sound of the Lung to Diagnose Lung Diseases

Phase: N/A

Role: Lead Sponsor

Start: Aug 31, 2010

Completion: Aug 31, 2015

NCT01225367

NCT01357746

Measuring Blood Pressure in the Lung Circulation With Sonar Technology (Echo-Doppler)

Phase: Phase 1

Role: Lead Sponsor

Start: Jul 31, 2011

Completion: Not specified

NCT01357746

NCT01361139

Diagnosis of Cardio-Pulmonary Pathology Using Transthoracic Parametric Doppler (TPD)

Phase: N/A

Role: Lead Sponsor

Start: Aug 31, 2011

Completion: Nov 30, 2014

NCT01618721

Detection and Characterization of Pulmonary Disease by Transthoracic Doppler (TTD)

Phase: N/A

Role: Lead Sponsor

Start: Dec 31, 2011

Completion: Not specified

NCT01618721

NCT02180113

Spleen Stiffness Measurement With FibroScan

Phase: N/A

Role: Lead Sponsor

Start: Mar 31, 2012

Completion: Jun 30, 2017

NCT02180113

NCT03548597

Evaluation of the Diagnostic of Hepatic Fibrosis With the in Severe Obese Patients Candidates to Bariatric Surgery

Phase: N/A

Role: Collaborator

Start: Apr 4, 2012

Completion: Dec 6, 2016

NCT03548597

NCT01744210

Evaluation of Blood Flow Patterns in Lung Blood Vessels Using Ultrasound Technique in Patients With Congestive Heart Failure

Phase: N/A

Role: Lead Sponsor

Start: Sep 30, 2012

Completion: Jul 31, 2015

NCT01831713

Pulmonary Blood Flow Measurements in CHF Patients

Phase: N/A

Role: Lead Sponsor

Start: Sep 30, 2012

Completion: Apr 30, 2015

NCT02575625

Fibroscan® Medical Device, Assessment for Non Invasive Diagnosis of Liver Steatosis

Phase: N/A

Role: Collaborator

Start: Apr 30, 2013

Completion: Oct 31, 2015

NCT01839786

Evaluation of Lung Doppler Signals in Pulmonary Hypertension

Phase: N/A

Role: Lead Sponsor

Start: May 31, 2013

Completion: Feb 28, 2017

NCT01913457

Measurements and Characterization of Doppler Signals From the Right Chest in Pediatric and Adult Patients

Phase: N/A

Role: Lead Sponsor

Start: Jul 31, 2013

Completion: Jul 1, 2021

NCT01913457

NCT01940328

Measurements of Doppler Signals Noninvasively From the Lung in Congestive Heart Failure

Phase: N/A

Role: Lead Sponsor

Start: Oct 31, 2013

Completion: Mar 31, 2016

NCT01985009

Prospective, Cross-sectional and Multicenter Study, Evaluating the Diagnosis Accuracy of the Controlled Attenuation Parameter(CAP) Measured by FibroScan® (Either With M+ or XL+ Probe) in Patient With Non-Alcoholic Fatty Liver Disease Using Liver Biopsy as Reference.

Phase: N/A

Role: Lead Sponsor

Start: Jan 31, 2014

Completion: Jan 17, 2017

NCT02061254

Transient Elastography DEdicated to Cosmetology And Dermatology (TEDECAD)

Phase: N/A

Role: Collaborator

Start: Apr 30, 2014

Completion: Jun 30, 2015

NCT02179203

Changes in Doppler Signals From the Lung Due to Cardiac Resynchronization in Heart Failure Patients

Phase: N/A

Role: Lead Sponsor

Start: Jul 31, 2014

Completion: Aug 31, 2015

NCT02243111

Detecting Pulmonary Arterial Hypertension (PAH) in Patients With Systemic Sclerosis (SSc) by Ultrasound

Phase: N/A

Role: Lead Sponsor

Start: Sep 30, 2014

Completion: Dec 31, 2015

NCT02246348

Evaluating Lung Doppler Signals in Patients With Systemic Sclerosis (SSc)

Phase: N/A

Role: Lead Sponsor

Start: Sep 30, 2014

Completion: Dec 31, 2015

NCT02248831

Evaluation of Cardiopulmonary Diseases by Ultrasound

Phase: N/A

Role: Lead Sponsor

Start: Sep 30, 2014

Completion: Dec 31, 2018

NCT01961141

Evaluation of Lung Doppler Signals in Patients Presenting to EMD

Phase: N/A

Role: Lead Sponsor

Start: Nov 30, 2014

Completion: Jun 30, 2015

NCT02278445

Evaluation of Pulmonary Doppler Signals in Patients With Systemic Sclerosis(SSc)

Phase: N/A

Role: Lead Sponsor

Start: Nov 30, 2014

Completion: Dec 31, 2015

NCT02339961

Evaluating Pulmonary Arterial Hypertension in Patients With Systemic Sclerosis

Phase: N/A

Role: Lead Sponsor

Start: Feb 28, 2015

Completion: Jan 31, 2016

NCT02652689

Diagnosis of Pulmonary Embolism by Doppler Signals

Phase: N/A

Role: Lead Sponsor

Start: Apr 30, 2016

Completion: Jan 31, 2019

NCT03385187

Prospective Validation Study of a Novel Type IV Home Sleep Apnea Test

Phase: N/A

Role: Lead Sponsor

Start: Jun 29, 2017

Completion: Dec 15, 2019

NCT03635918

Extensive Prospective Validation Study of the NightOwl Home Sleep Apnea Test

Phase: N/A

Role: Lead Sponsor

Start: Aug 15, 2018

Completion: Sep 15, 2019

NCT03774199

NightOwl Pulse Oximeter Calibration Study

Phase: N/A

Role: Lead Sponsor

Start: Dec 14, 2018

Completion: Apr 14, 2020

NCT03998410

Evaluation of the Diagnostic Value of the TPD System in Determining ADHF Causing Acute Dyspnea

Phase: N/A

Role: Lead Sponsor

Start: Sep 15, 2019

Completion: Jul 1, 2021

NCT03872024

Performances Evaluation of New FibroScan Probes Dedicated to Morbidly Obese Patients

Phase: N/A

Role: Lead Sponsor

Start: Sep 19, 2019

Completion: Mar 24, 2022

NCT03704792

Validation of the Second Generation of the Controlled Attenuation Parameter (CAP) Using the MRI-PDFF as Reference

Phase: N/A

Role: Lead Sponsor

Start: Sep 24, 2019

Completion: Nov 30, 2021

NCT04191668

A Validation Study of the NightOwl PAT-based Home Sleep Apnea Test

Phase: N/A

Role: Lead Sponsor

Start: Dec 2, 2019

Completion: Feb 1, 2020

NCT04194073

NightOwl SpO2 Calibration Study

Phase: N/A

Role: Lead Sponsor

Start: Dec 7, 2019

Completion: Jan 31, 2020

NCT03778411

Non-invasive Evaluation of Portal Hypertension in Patients With Compensated Advanced Chronic Liver Disease by Assessment of Spleen Stiffness Using VCTE by FibroScan.

Phase: N/A

Role: Collaborator

Start: Dec 1, 2020

Completion: Mar 3, 2023

NCT04764734

A Validation Study of the NightOwl Home Sleep Apnea Test

Phase: N/A

Role: Lead Sponsor

Start: Mar 20, 2021

Completion: Sep 10, 2022

NCT04747457

Development of Predictive Indicators of Homogeneous Propagation of Ultrasound and Elastic Waves During VCTE Examination